Many patients come to our Grand Rapids clinic after researching ketamine treatment on their own. They may understand the basics but still have an important question: What is the difference between a standard IV ketamine infusion and ketamine-assisted psychotherapy, and how do I know which approach is right for me?
At Thrive Center for Health, we do not treat this as a choice between a basic option and a better one. Both approaches involve careful screening, clinical monitoring, and individualized planning. The meaningful difference is how psychotherapy is incorporated into the treatment experience.
The right path depends on your symptoms, treatment history, goals, readiness for therapeutic work, current care team, and personal preferences. We take time to understand those factors before making a recommendation.
What Standard Infusions and KAP Have in Common
At our clinic, both standard infusions and ketamine-assisted psychotherapy use IV ketamine administered in a monitored clinical setting.
Before either treatment begins, patients complete psychiatric and medical evaluations. We review diagnoses, symptoms, medications, previous treatment responses, relevant medical conditions, and factors that could affect safety or candidacy.
During an infusion, ketamine is delivered through an IV at a subanesthetic dose. Patients remain conscious and able to communicate, although temporary changes in perception, awareness, and the sense of time or surroundings can occur.
Our team monitors vital signs and remains available throughout the appointment. Afterward, patients spend time recovering before leaving with a responsible driver.
You can learn more about the setting and process through our overview of the ketamine treatment experience.
Both approaches also require realistic expectations. IV ketamine is used off-label for psychiatric conditions. Individual responses vary, and neither a standard infusion nor KAP can guarantee a particular outcome.
What We Mean by a Standard IV Ketamine Infusion
A standard infusion centers on the medication treatment itself.
Patients receive IV ketamine in a private room while our clinical team provides continuous monitoring and support. The experience may feel relaxing, dreamlike, emotionally significant, or unfamiliar. Some patients notice vivid imagery or a sense of distance from their usual thoughts and surroundings. Others have a quieter or more abstract experience.
Although our team is present to support the patient, a standard infusion does not include structured psychotherapy during the medication session. Patients are not expected to analyze the experience, follow a therapeutic agenda, or discuss difficult material while the infusion is underway.
This can be a good fit for patients who:
- Want to focus primarily on the medical treatment
- Already have an established therapist for ongoing psychological care
- Prefer a quieter and less verbally interactive session
- Are not currently interested in combining the infusion with formal psychotherapy
- Want to evaluate their response to IV ketamine before considering additional therapeutic support
These are considerations rather than fixed rules. We do not assume that a diagnosis or level of symptom severity automatically determines which format a patient should receive.
Our guide to what happens during a first ketamine infusion provides a closer look at preparation, monitoring, recovery, and transportation requirements.
How Ketamine-Assisted Psychotherapy Changes the Framework
Ketamine-assisted psychotherapy, often abbreviated as KAP, adds structured therapeutic support to the ketamine experience.
At Thrive, a therapist helps the patient prepare for the session, remains present during the infusion, and supports integration afterward. Preparation may include discussing goals, concerns, boundaries, expectations, and the emotional material a patient hopes to explore.
During the infusion, the therapist provides a calm and supportive presence. The patient is not required to talk continuously or force a particular experience. Instead, the therapist can help the patient remain grounded and can note themes or insights that may be useful during later integration.
Integration occurs as the immediate effects of ketamine subside and during follow-up work after the treatment. The purpose is to help the patient reflect on what emerged and consider how any meaningful themes relate to daily life, relationships, habits, or ongoing therapy.
Our ketamine-assisted psychotherapy service explains how we structure this preparation, therapist support, and integration.
What the Evidence Can and Cannot Tell Us About KAP
Research on combining ketamine with psychotherapy is promising, but it is still developing.
Published studies have used different forms of psychotherapy, ketamine routes, doses, schedules, diagnoses, and treatment sequences. Some provide psychotherapy before ketamine, some during the medication session, and others primarily after treatment. This variation makes it difficult to compare results or define one evidence-based KAP protocol that applies to every patient.
There is preliminary evidence that psychotherapy may help some patients build on or sustain improvements associated with ketamine. However, current research does not establish that KAP is consistently more effective than medically monitored ketamine treatment alone.
It also does not give clinicians a dependable formula for deciding which patients will benefit more from one approach than the other.
For that reason, we do not describe integration as the component that guarantees lasting change. We view it as a therapeutic opportunity that may be valuable for some patients, depending on their needs and willingness to engage.
Our article on what KAP is and how it works offers more detail about the approach while acknowledging the limits of the current evidence.
Why One Approach Is Not Automatically Better
A standard infusion and KAP are designed around different treatment experiences. One is not automatically more advanced, more serious, or more appropriate.
Some patients value having uninterrupted space during an infusion. They may prefer to process the experience privately or discuss it later with a therapist who already knows them well.
Other patients want psychotherapy built directly into the process. They may feel more comfortable with a therapist present or may want help preparing for and reflecting on emotions, memories, or perspectives that arise.
A patient can also be interested in KAP without having a trauma history. Likewise, a diagnosis such as PTSD does not automatically mean KAP is the correct choice. For a broader look at how PTSD intersects with ketamine treatment, our post on alternative PTSD treatment in Grand Rapids provides helpful context.
Diagnosis matters, but it is only one part of the decision. We also consider the patient’s stability, support system, treatment goals, therapy history, communication preferences, and comfort with the structure of each option.
How We Help Patients Choose
Our recommendation begins with a conversation, not a sales pitch.
We ask what you hope treatment will change and what previous care has been like. We want to know whether you currently work with a therapist, whether that relationship feels helpful, and whether your existing provider can support you between ketamine appointments.
We also discuss how you tend to respond to emotionally intense experiences. Some patients feel safer with active therapeutic support. Others feel pressured or distracted when asked to talk during a vulnerable experience.
Questions we may explore include:
- Are you primarily seeking a medication-based intervention?
- Do you want psychotherapy integrated into the ketamine sessions?
- Are you comfortable exploring difficult emotions or memories?
- Do you already have a therapist you trust?
- How much structure do you prefer during treatment?
- Are you able to attend preparation and integration appointments?
- What practical or financial considerations may affect your choice?
- What would make the experience feel safe, respectful, and manageable?
There is no correct set of answers. These questions help us understand how each option may fit your circumstances.
Why Screening Comes Before Either Treatment
Whether a patient is considering standard infusions or KAP, screening is essential.
Our ketamine therapy screening process includes both psychiatric and medical evaluation. We assess the condition being treated, previous care, current medications, physical health, psychiatric stability, substance-use history, and other factors that may affect treatment.
Ketamine can temporarily increase blood pressure and heart rate and may cause nausea, dizziness, perceptual changes, anxiety, or dissociation. Certain medical and psychiatric concerns may require additional evaluation, changes to the plan, or a different treatment recommendation.
We also establish a baseline for tracking progress. A meaningful treatment decision should consider changes in symptoms and functioning—not only whether the medication experience felt pleasant, unusual, or emotionally significant.
KAP requires the same medical safeguards as a standard infusion. The presence of a therapist does not replace appropriate screening, medication review, vital-sign monitoring, or post-treatment observation.
The Role of the Treatment Environment
The setting surrounding a ketamine session can influence how comfortable and supported a patient feels, even though the environment itself is not a substitute for clinical care.
Our Grand Rapids treatment rooms are private and designed to reduce unnecessary stimulation. We use soft lighting and music while maintaining the monitoring and access our team needs to provide safe care.
For KAP patients, the environment must also support privacy, trust, and communication with the therapist. For standard-infusion patients, it should allow quiet and personal space without leaving the patient medically unattended.
We explain more about these choices in our look inside Thrive’s purpose-built treatment environment.
Can a Treatment Plan Change Over Time?
Yes. A patient’s plan does not always have to remain fixed from the first appointment onward.
Someone may begin with standard infusions and later decide that integrated psychotherapy would support their goals. Another patient may participate in KAP and determine that future infusions would be better suited to a quieter format.
A change in approach should follow clinical discussion rather than happen automatically. We consider response, tolerability, current symptoms, therapeutic readiness, and what the patient has learned about their preferences.
We also coordinate with outside therapists and psychiatric providers when the patient authorizes communication and collaboration would support continuity of care.
Starting treatment with us does not necessarily mean ending helpful relationships with clinicians who already know your history.
Cost, Scheduling, and Practical Considerations
KAP includes therapist time for preparation, support during treatment, and integration. This can create different scheduling and financial considerations from a standard infusion.
Because fees, insurance benefits, and treatment structures can change, we do not want patients relying on a general blog post for a personal cost estimate. We discuss current pricing and the components of each option before a patient commits to treatment. For a general overview of what ketamine treatment involves financially, our page on how much ketamine treatment costs in Michigan offers a useful starting point.
Patients may also want to consider the time required for additional appointments, transportation after ketamine treatment, time away from work, and the availability of support at home.
These practical concerns are legitimate parts of the decision. We want patients to understand both the clinical rationale and the real-world commitment associated with the plan we discuss.
Frequently Asked Questions
What is the main difference between KAP and a standard infusion?
At our clinic, both involve IV ketamine administered with clinical monitoring. A standard infusion focuses on the medication treatment and does not include structured psychotherapy during the session. KAP adds therapeutic preparation, the presence of a therapist during treatment, and integration afterward.
Is KAP more effective than a standard infusion?
Current research does not establish that KAP is consistently more effective for every patient or condition. Studies combining ketamine and psychotherapy have produced encouraging findings, but protocols vary considerably and direct comparisons remain limited. We discuss KAP as one option with potential benefits and unresolved questions—not as a guaranteed improvement over standard care.
Is KAP only for patients with PTSD or trauma?
No. A trauma history may be relevant to the conversation, but it does not automatically determine the treatment format. KAP may appeal to patients who want structured therapeutic support or who hope to explore psychological patterns as part of treatment. We still assess whether the approach fits the patient’s diagnosis, stability, goals, and readiness.
Do I have to talk throughout a KAP infusion?
No. KAP does not require continuous conversation or a forced emotional breakthrough. The therapist is present to support the patient and respond when needed. Some sessions may involve discussion, while others may remain relatively quiet. Preparation helps establish expectations and preferences in advance.
Can I keep working with my current therapist?
In many cases, yes. Some patients receive standard infusions with us and complete psychotherapy with an outside provider. KAP patients may also continue an established therapy relationship. With your permission, we can coordinate with other members of your care team when appropriate.
Will I need to stop my current medication?
Not necessarily. We review medications during screening because some may affect treatment planning. Never stop or change a psychiatric medication without guidance from the prescribing provider and our clinical team.
How many sessions will I need?
There is no universal schedule that applies to every patient. The number and timing of infusions, preparation appointments, integration sessions, and possible maintenance care depend on the treatment plan and response. We explain the proposed structure before treatment begins and reassess it as care progresses.
Key Takeaways
- At Thrive, both standard infusions and KAP use IV ketamine administered in a monitored clinical setting.
- A standard infusion centers on the medication treatment without structured psychotherapy during the session.
- KAP adds therapeutic preparation, therapist support during treatment, and integration afterward.
- Early evidence for combining ketamine and psychotherapy is promising, but research protocols vary and do not prove that KAP is better for every patient.
- Diagnosis alone does not determine which format is appropriate.
- We consider treatment goals, therapy history, readiness, preferences, support, cost, and clinical safety.
- Patients complete psychiatric and medical screening before either approach.
- IV ketamine for psychiatric conditions is an off-label use, individual outcomes vary, and no result can be guaranteed.
Choosing the Approach That Fits You
Choosing between ketamine-assisted psychotherapy and a standard IV infusion is not a decision we expect you to make from a web page alone.
At Thrive Center for Health, we help you understand what each option involves, what the research supports, and where uncertainty remains. We listen to your goals, review your treatment history, and consider how you prefer to receive support.
Our goal is not to steer every patient toward the same service. It is to recommend an approach that is clinically appropriate, clearly explained, and aligned with the person receiving care.
When you are ready to discuss which option may fit your situation, you can contact our Grand Rapids team.
About Thrive Center for Health
At Thrive Center for Health in Grand Rapids, Michigan, we work with patients who have complex mental health and chronic pain histories, including people who have not found adequate relief through standard treatment.
We provide IV and IM ketamine therapy, ketamine-assisted psychotherapy, psychiatric medication management, and complementary patient support. Our clinic includes private treatment rooms, continuous clinical monitoring, and an environment designed around comfort, dignity, and honest communication.
Our care culture is grounded in five values: compassionate, approachable, inspiring, dedicated, and authentic.
Thrive Center for Health is located at 847 Parchment Drive SE, Suite 105, Grand Rapids, MI 49546.
Medical Disclaimer
This content is provided for educational purposes only and does not constitute medical advice, diagnosis, or an individualized treatment recommendation. IV ketamine for psychiatric conditions is an off-label use and may not be appropriate for every patient. Individual results vary, and no outcome can be guaranteed. Always consult a qualified healthcare provider before starting, stopping, or changing a medication or treatment.
If you are experiencing suicidal thoughts or an emotional crisis, call or text 988. Call 911 or go to the nearest emergency department if there is an immediate danger to you or someone else.
Works Cited
Drozdz, S. J., Goel, A., McGarr, M. W., et al. (2022). Ketamine assisted psychotherapy: A systematic narrative review of the literature. Journal of Pain Research, 15, 1691–1706.
Kew, B. M., Porter, R. J., Douglas, K. M., Glue, P., & Mentzel, C. L. (2023). Ketamine and psychotherapy for the treatment of psychiatric disorders: Systematic review. BJPsych Open, 9(3), e79.
Murrough, J. W., Iosifescu, D. V., Chang, L. C., et al. (2013). Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial. American Journal of Psychiatry, 170(10), 1134–1142.
Phillips, J. L., Norris, S., Talbot, J., et al. (2019). Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: A randomized controlled trial. American Journal of Psychiatry, 176(5), 401–409.
Sanacora, G., Frye, M. A., McDonald, W., et al. (2017). A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74(4), 399–405.
Wilkinson, S. T., Rhee, T. G., Joormann, J., et al. (2021). Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: A randomized clinical trial. Psychotherapy and Psychosomatics, 90(5), 318–327.